Targeted Oncology

FDA Expands Approval of Aptima HPV Assay for Cervical Cancer Primary Screening

The FDA has expanded the approval of Hologic’s Aptima human papillomavirus (HPV) assay for clinician-collected primary ...
Rutland Herald

Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio

Hologic, Inc. (Nasdaq: HOLX) announced today that its Aptima ® HPV Assay received FDA approval for clinician-collected HPV primary screening. Hologic’s human papillomavirus (HPV) test is the only ...
KTVZ

HPV testing preferred over Pap for cervical cancer screening starting at age 30, task force’s draft recommendation says

(CNN) — Testing for high-risk human papillomaviruses every five years – even with a self-collected sample – is the “preferred screening strategy” for cervical cancer starting at age 30, according to a ...
clinicaladvisor.com

Primary-care CRC screening lacking

Fewer than one in five U.S. primary-care physicians follow practice guidelines for all recommended colorectal cancer (CRC) screening modalities. After examining survey data from 1,266 physicians ...